HealthDay News — The American Academy of Pediatrics (AAP) is suing the US Department of Health and Human Services (HHS), seeking to stop nearly $12 million in federal funding cuts that it says put ...

The researchers found that 6.5% of adults experienced cost burdens and 3.5% had CCBs during year one; 17.4% and 9.9%, respectively, experienced these outcomes at least once over 4 years. Overall, 24.7 ...

Receipt of educational leaflet also reduces misperception of asymptomatic bacteriuria as urinary tract infection.

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

In a landmark legal settlement approved last week, Aetna agreed to cover fertility treatments for same-sex couples the same way it does for heterosexual couples. The deal applies nationwide and is ...

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...

Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.

Adults with congenital heart disease benefit from routine care at ACHD centers and collaboration with ACHD cardiologists ...

(HealthDay News) — The US Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, ...

The Food and Drug Administration (FDA) has approved Myqorzo™ (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and ...

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.